MedPath
HSA Approval

PROMETHAZINE 5 MG SYRUP 5 mg/5 ml

SIN10327P

PROMETHAZINE 5 MG SYRUP 5 mg/5 ml

PROMETHAZINE 5 MG SYRUP 5 mg/5 ml

October 28, 1998

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R06AD02

promethazine

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE LTD

Active Ingredients

PROMETHAZINE HCl

5 mg/5 ml

Promethazine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROMETHAZINE 5 MG SYRUP 5 mg/5 ml - HSA Approval | MedPath